Heads up:
@BioProtocol is wiring the financial layer for biotech with
@BiomeAI, taking DeSci from talk to traction
On the Bio App you can:
↳ Join or launch BioDAOs
↳ Fund labgrade experiments on-chain
↳ Tokenize IP and govern with BIO primitives
↳ Collaborate with AI-driven BioAgents
↳ Stake EDMT & BIOMEAI, earn BioXP, deploy it in IP-Token and BioAgent Ignition Sales
Capital = compute, and compute accelerates discovery. This is how compounds that would rot in a desk drawer get tokenized, funded by a global community, and pushed through real development cycles. No gatekeepers, transparent allocations, conviction over churn, data flowing back to the people who put skin in the game
Signal check from ignition szn:
$BIOME ran 20x
$EDT crossed 10x
Early, but it shows the market wants permissionless science with clear upside alignment
Expansion thoughts already surfacing:
↳ Bio crosschain hops widen liquidity and participation
↳ MicrobiomeDAO scaling via Asia meetups and biohacker nets
↳ Rev-share paths in gut tech with longevity crossovers
↳ University collabs open IP rails for faster translation
What I’m watching next:
• More IP-Token launches with visible readouts
• BioAgent swarms assisting protocol dev and experiment design
• Staking flywheel turning BioXP into real participation power
• Researchers, builders, and retail converging on the same transparent funding stack
If you’re reading this, you’re early. Support a system where science is shared, governed, and built in the open, and let value circle back to the contributors who actually move it forward
#DeSci #BioTech #AI #Blockchain